TENX — Tenax Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Tenax Therapeutics Inc

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatmen… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$11.88
Market Cap$328M
Float10.6M
Shares Outstanding26.5M
P/E (Forward)0.30
Price/Sales (TTM)414.72
vs. Analyst Target+150.1% to analyst PT
Dividend RateNone
Analyst Target Price$29.71 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$9.9M -$114,748 -$9.7M
2021 N/A -$32.5M -$108,982 -$32.4M
2022 N/A -$11.0M -$113,332 -$10.9M
2023 N/A -$7.7M -$7,570 -$7.7M
2024 N/A -$17.6M N/A -$17.6M
2025 N/A -$52.6M N/A -$56.4M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$10.8M
Sep 2025 N/A -$15.8M
Dec 2025 N/A -$15.5M
Mar 2026 N/A -$15.7M

Ownership & Float

Insider Ownership0.1%
Institutional Ownership84.4%
Short Float6.9%
% of All Funds Holding0.86%
Number of Funds Holding71

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$13.35Near-term / short-term trend
Weekly40-Week SMA$10.88Medium-term trend
Weekly80-Week SMA$8.46Cyclical trend (business cycle)
Weekly200-Week SMA$46.12Secular trend (multi-year)
Monthly10-Month SMA$10.80Near-term monthly trend
Monthly20-Month SMA$8.32Medium-term monthly trend
Monthly40-Month SMA$13.05Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$15.90 resistance 2.83x 0 months ago
$9.30 support 3.20x 4 months ago
$7.50 support 1.56x 5 months ago
$6.00 support 2.80x 7 months ago

Historical Earnings Reactions (102 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.19% 0.00% 42.16% 9.59% -19.48%
1 Day -0.74% 0.00% 44.12% 20.83% -18.55%
1 Week 0.77% 0.00% 49.02% 55.17% -41.77%
2 Weeks 0.37% -1.17% 39.60% 74.71% -44.47%
1 Month 1.35% -1.89% 41.58% 177.78% -70.44%

Next earnings: July 31, 2026 (64 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-2.4%31.3%32
Feb13.4%28.1%32
Mar9.1%40.6%32
Apr-3.6%31.3%32
May1.2%43.8%32
Jun-6.9%31.3%32
Jul0.9%40.6%32
Aug-0.5%34.4%32
Sep-6.8%18.8%32
Oct0.9%46.9%32
Nov6.7%43.8%32
Dec0.4%46.9%32

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.17% 38.8% 1519
Tuesday -0.01% 38.7% 1662
Wednesday 0.37% 42.1% 1659
Thursday 0.06% 38.7% 1627
Friday 0.43% 41.5% 1622

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 84.4%

Insider Transactions — Smart Summary

Total insider ownership: 0.1%

12-Month Insider Activity Summary

Total Filings6
Net Value+$174,577.938
Net Shares Change24,591
% of Float0.2%
C-Suite Filings4
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Rich Stuart Chief Medical Officer +$96,414.25 2 4 buy
MCGAULEY THOMAS Interim CFO +$58,163.8 1 2 buy
Almenoff June Sherie +$29,889.42 2 2 buy
Giordano Christopher Thomas CEO +$19,999.888 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-11-19 – 2025-11-20 4 3 +$108,053.107 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-10 Rich Stuart Chief Medical Officer +$50,792.5 Transaction at $10.16, now +16.9%
2025-12-05 Rich Stuart Chief Medical Officer +$45,621.75 Transaction at $9.12, now +30.2%
2025-11-19 MCGAULEY THOMAS Interim CFO +$58,163.8 Transaction at $7.29, now +62.9%
2025-11-20 Giordano Christopher Thomas CEO +$19,999.888 Transaction at $7.68, now +54.7%
2025-11-20 Almenoff June Sherie +$14,944.71 Transaction at $7.50, now +58.4%
2025-11-19 Almenoff June Sherie +$14,944.71 Transaction at $7.50, now +58.4%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Tenax Therapeutics Inc (TENX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for TENX on Trend Edge →